Determination of glycated hemoglobin in patients with advanced liver disease

World Journal of Gastroenterology

Volumn 10, Issue 15, 2004, Pages 2284-2286

  Lahousen, Theresa ^a   Hegenbarth, Karin ^a   Ille, Rottraut ^a   Lipp, Rainer W ^a   Krause, Robert ^a   Little, Randie R ^b   Schnedl, Wolfgang J ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; NITROBLUE TETRAZOLIUM; RIBAVIRIN;

ANALYTIC METHOD; ANEMIA; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE COUNT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; ION EXCHANGE CHROMATOGRAPHY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LONG TERM CARE; RETICULOCYTE COUNT; RETICULOCYTOSIS;

EID: 4344711581     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i15.2284     Document Type: Article

References (13)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
2. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281: 2005-2012
3. Shetty A, Wilson S, Kuo P, Laurin JL, Howell CD, Johnson L, Allen EM. Liver transplantation improves cirrhosis-associated impaired oral glucose tolerance. Transplantation 2000; 69: 2451-2454
4. Trenti T, Cristani A, Cioni G, Pentore R, Mussini C, Ventura E. Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis. Ric Clin Lab 1990; 20: 261-267
5. Cacciatore L, Cozzolino G, Giardina MG, De Marco F, Sacca L, Esposito P, Francica G, Lonardo A, Matarazzo M, Varriale A. Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated hemoglobin levels in chronic liver disease. Diabetes Res 1988; 7: 185-188
6. 1 in cirrhosis of the liver. Diabetes Res 1989; 11: 177-180
7. 1c can be assessed with erythrocyte creatine in patients with shortened erythrocyte age. Diabetes Care 1998; 21: 1732-1735
8. Bravo AA, Sheth SG, Chopra S. Current concepts: liver biopsy. N Engl J Med 2001; 344: 495-500
9. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, Gallois Y, Rifflet H, Maiga MY, Penneau-Fontbonne D, Cales P. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113: 1609-1616
10. De Franceschi L, Fattovich G, Turrini F, Ayi K, Brugnara C, Manzato F, Noventa F, Stanzial AM, Solero P, Corrocher R. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C infection: role of membrane oxidative damage. Hepatology 2000; 31: 997-1004
11. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001; 47: 1985-1992
12. 1c. Diabetes Care 2002; 25: 275-278
13. Maruyama S, Hirayama C, Yamamoto S, Koda M, Udagawa A, Kadowaki Y, Inoue M, Sagayama A, Umeki K. Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 2001; 138: 332-337